PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Meptazinol - Pain (non-malignant)
PAD Profile : Meptazinol - Pain (non-malignant)
Keywords :
opioid, analgesic, analgesia, PNMP, non-malignant
Brand Names Include :
Meptid
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Tapentadol hydrochloride
- Oxycodone
- Co-codamol (Codeine phosphate/paracetamol)
- Tramadol hydrochloride
- Tramadol hydrochloride
- Codeine phosphate
- Buprenorphine
- Morphine sulfate
- Pregabalin
- Gabapentin
- Co-dydramol (Dihydrocodeine/paracetamol)
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
06 June 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Meptazinol (Meptid) is not recommended as a treatment option for persistent non-malignant pain and will be considered BLACK on the traffic light system.
Please see the persistent non- malignant guidelines attached below for information on prescribing for this indication.
Meptazinol is associated with rebound pain and an unacceptable level of side effects and therefore is not recommended to be prescribed routinely.
Associated BNF Codes
04. Central Nervous System
04.07.02. Opioid analgesics